Sort
65,743 grants matching “single cell sequencing”
Molecular, Cellular, and Tissue Characterization Unit
$1,008,368Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2021 · CA
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
$1,008,279Christine Cheng · Boston University (Charles River Campus) · R61 · FY2018 · DA
Molecular Genetics Of Early Eye Development
$1,008,019Stanislav I Tomarev · National Eye Institute · ZIA · FY2025 · EY
Clinical ophthalmic molecular diagnostics and discovery
$1,008,019Bin Guan · National Eye Institute · ZIA · FY2025 · EY
Single-cell in situ analysis of RNA modifications in intact tissues
$1,008,000Xiao Wang · Broad Institute, Inc. · DP2 · FY2024 · GM
SARS-CoV-2 Studies
$1,007,948Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Functional decoding of signaling dynamics in single immune cells
$1,007,833Myong-Hee Sung · National Institute On Aging · ZIA · FY2018 · AG
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$1,007,803Justin Kawika Ichida · University Of Southern California · R01 · FY2022 · NS
Regulation of Oxytocin and Vasopressin Gene Expression in the hypothalamus.
$1,007,762Harold Gainer · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Telomere maintenance and replication fork progression in yeast and human cells
$1,007,612Virginia A. Zakian · Princeton University · R35 · FY2020 · GM
Transgenic Core Facility
$1,007,286Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Network basis of action selection
$1,006,847Anatol C Kreitzer · J. David Gladstone Institutes · U01 · FY2017 · NS
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$1,006,666Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2019 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,005,764Pablo Tamayo · University Of California, San Diego · U01 · FY2020 · CA
Studies of nucleoprotein complexes involved in retroviral DNA integration
$1,005,632Robert Craigie · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Studies of nucleoprotein complexes involved in retroviral DNA integration
$1,005,632Robert Craigie · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Virology
$1,005,592George M Shaw · Beth Israel Deaconess Medical Center · U19 · FY2014 · AI
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,005,497Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,005,497Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
$1,005,360Andrew J. Gentles · Stanford University · U01 · FY2025 · CA
Physical Resources Core
$1,005,214Justin Joseph Pollara · Duke University · P01 · FY2025 · AI
Mechanisms of transcription factor integration at the c-myc promoter
$1,005,097David Levens · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
The genome-wide function of supercoiling and alternative DNA conformations
$1,005,097David Levens · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
High-throughput detection of transcriptomic and epitranscriptomic variation and kinetics using MarathonRT
$1,005,089Anna Marie Pyle · Yale University · R01 · FY2021 · HG
Embryonic origins of endothelial heterogeneity
$1,005,000Nathan D Lawson · Univ Of Massachusetts Med Sch Worcester · R35 · FY2023 · HL